Community led response to COVID-19 in Colombia
Glasgow researchers and Colombian collaborators work toward community led understanding and responses to the challenges of COVID-19 within indigenous and Afro-Colombian communities.
Animal African Trypanosomiasis
Capacity strengthening projects in Africa
- Population biology and genomic studies of Anopheles funestus in Tanzania; Bill and Melinda Gates Foundation, £338k (2020-23).
- Identification of genomic components that predict transmission of the malaria parasite in different vector species; Wellcome Trust, £1M (2020-25).
- US-UK collaboration: Integrating animal ecology, epidemiology, and human interests for strategic zoonosis management in a complex wildlife reservoir; BBSRC, £550k (2020-23).
- Cattle vaccination against malignant catarrhal fever: balancing pastoral livelihoods, food security and ecosystem integrity in the Serengeti, Tanzania; BBRSC, £223k (2020-21).
- Malaria mosquito research could provide new control tools
- Risk of viruses emerging in humans may not depend on their animal host
- Bacteria used to control the mosquito-borne viruse dengue in the wild
- Drug discovery offers new hope to halt the spread of malaria
- A new way to block malaria transmission by targeting young contagious parasite forms
- Professor Sarah Cleaveland elected to join Academy of Medical Sciences
- Viral zoonotic risk is homogenous among taxonomic orders of mammalian and avian reservoir hosts. PNAS (2020).
- Establishment of Wolbachia Strain wAlbB in Malaysian Populations of Aedes aegypti for Dengue Control. Current Biology (2020).
- Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target. Science (2019).
- Naturally acquired immunity against Plasmodium falciparum immature gametocytes. Science Translational Medicine (2019).
- Drug resistance in eukaryotic microorganisms. Nature Microbiology (2016)
Glasgow is an international leader in One Health research.
We seek to improve human and animal health by addressing questions that arise as a result of the many and diverse interdependencies between these two domains.
One Health approaches cannot be confined to the study of either human or veterinary medicine, or even to a combination of the two. Instead, the effective resolution of health questions depends critically on understanding the complex biological and social, economic, political and environmental contexts in which those questions are embedded. With the growing recognition of the importance of multimorbidity, this area of research has expanded to include the study of interactions between infectious and non-communicable disease.
These complex issues are most powerfully addressed through interdisciplinary collaborations. At Glasgow, researchers from human and veterinary clinical medicine are closely integrated with life scientists, and interface with social and physical scientists to deliver world-changing research. We work both across the Global South with a focus on sub-Saharan Africa, particularly Tanzania and Malawi, and in Scotland and the rest of the UK.
Our collaborations have made a significant impact on key national, global health and veterinary agendas.